The FDA has not evaluated the safety or effectiveness of compounded BPC-157 for these indications
The SURPASS clinical trial program demonstrated that tirzepatide at its highest dose (15 mg weekly) produced average weight loss of 20-25% of body weight, significantly exceeding the results seen with GLP-1 only agonists
Not having enough can cause tiredness, brain issues, and big red blood cells
But that could change soon: This July, the Pharmacy Compounding Advisory Committee (PCAC) will discuss whether peptides such as BPC-157, TB-500, MOTS-c, and Semax (among others) should be included on the FDAs 503A Bulks List
In its absence, peripheral neuropathy can occur, leading to numbness in your extremities
Tucson Wellness MD stands as your steadfast partner, committed to guiding you on the journey to becoming the absolute best version of yourself